Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H41N5O7 |
Molecular Weight | 463.5688 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 13 / 13 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]1(CC[C@@H](N)[C@@]([H])(O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)[C@@H](C)N
InChI
InChIKey=XUFIWSHGXVLULG-IDLVJFIQSA-N
InChI=1S/C20H41N5O7/c1-8(21)12-5-4-9(22)18(30-12)31-15-10(23)6-11(24)16(13(15)26)32-19-14(27)17(25-3)20(2,28)7-29-19/h8-19,25-28H,4-7,21-24H2,1-3H3/t8-,9-,10+,11-,12+,13+,14-,15-,16+,17-,18-,19-,20+/m1/s1
Gentamicin C2 together with epimer C2a is a part of the antibiotic of the aminoglycoside group, gentamicin. Gentamicin C2 has a methyl group in the 6′ position. Gentamicin is a broad-spectrum antibiotic that binds to the prokaryotic ribosome, inhibiting protein synthesis in susceptible bacteria. Gentamicin is bactericidal in vitro against Gram-positive and Gram-negative bacteria.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2363
Created by
admin on Fri Dec 15 16:27:24 GMT 2023 , Edited by admin on Fri Dec 15 16:27:24 GMT 2023
|
||
|
FDA ORPHAN DRUG |
513215
Created by
admin on Fri Dec 15 16:27:24 GMT 2023 , Edited by admin on Fri Dec 15 16:27:24 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3P99H114B8
Created by
admin on Fri Dec 15 16:27:24 GMT 2023 , Edited by admin on Fri Dec 15 16:27:24 GMT 2023
|
PRIMARY | |||
|
25876-11-3
Created by
admin on Fri Dec 15 16:27:24 GMT 2023 , Edited by admin on Fri Dec 15 16:27:24 GMT 2023
|
PRIMARY | |||
|
C76150
Created by
admin on Fri Dec 15 16:27:24 GMT 2023 , Edited by admin on Fri Dec 15 16:27:24 GMT 2023
|
PRIMARY | |||
|
m5697
Created by
admin on Fri Dec 15 16:27:24 GMT 2023 , Edited by admin on Fri Dec 15 16:27:24 GMT 2023
|
PRIMARY | Merck Index | ||
|
28292
Created by
admin on Fri Dec 15 16:27:24 GMT 2023 , Edited by admin on Fri Dec 15 16:27:24 GMT 2023
|
PRIMARY | |||
|
C100093
Created by
admin on Fri Dec 15 16:27:24 GMT 2023 , Edited by admin on Fri Dec 15 16:27:24 GMT 2023
|
PRIMARY | |||
|
DTXSID9023093
Created by
admin on Fri Dec 15 16:27:24 GMT 2023 , Edited by admin on Fri Dec 15 16:27:24 GMT 2023
|
PRIMARY | |||
|
72397
Created by
admin on Fri Dec 15 16:27:24 GMT 2023 , Edited by admin on Fri Dec 15 16:27:24 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)